KEY FEATURES
Full Name | Glypican 3 |
---|---|
Synonym | DGSX; OCI5; SDYS; SGB; SGBS1; MXR7; Glypican Proteoglycan 3; GTR2-2; Intestinal protein OCI-5; Secreted glypican-3 |
Assay Type | Sandwich |
Reactivity | Mouse |
Range | 0.014-10ng/mL |
Sensitivity | 0.005ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Mouse GPC3 in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse GPC3. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse GPC3 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse GPC3, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse GPC3. You can calculate the concentration of Mouse GPC3 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse GPC3 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 0.51 | 1.36 | 4.24 | 0.48 | 1.26 | 4.3 |
Standard deviation | 0.03 | 0.07 | 0.15 | 0.03 | 0.07 | 0.19 |
CV(%) | 6.69 | 4.88 | 3.56 | 5.83 | 5.56 | 4.36 |
RECOVERY
The recovery of Mouse GPC3 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 95-111 | 101 |
EDTA plasma (n=8) | 86-99 | 92 |
Cell culture media (n=8) | 84-96 | 90 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse GPC3 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with GPC3 ELISA Kits
GPC4 ELISA Kit | publications with GPC3 and GPC4 |
FGF2 ELISA Kit | publications with GPC3 and FGF2 |
SDC1 ELISA Kit | publications with GPC3 and SDC1 |
IGF2 ELISA Kit | publications with GPC3 and IGF2 |
SHH ELISA Kit | publications with GPC3 and SHH |
SDC2 ELISA Kit | publications with GPC3 and SDC2 |
SDC3 ELISA Kit | publications with GPC3 and SDC3 |
WNT3A ELISA Kit | publications with GPC3 and WNT3A |
EXT2 ELISA Kit | publications with GPC3 and EXT2 |
PTCH1 ELISA Kit | publications with GPC3 and PTCH1 |
Pathways associated with GPC3 ELISA Kit
A Tetrasaccharide Linker Sequence Is Required For GAG Synthesis Pathway | A Tetrasaccharide Linker Sequence Is Required For GAG Synthesis Pathway |
Chondroitin Sulfate/dermatan Sulfate Metabolism Pathway | Chondroitin Sulfate/dermatan Sulfate Metabolism Pathway |
Disease Pathway | Disease Pathway |
Diseases Associated With Visual Transduction Pathway | Diseases Associated With Visual Transduction Pathway |
Glycosaminoglycan Metabolism Pathway | Glycosaminoglycan Metabolism Pathway |
Glypican 3 Network Pathway | Glypican 3 Network Pathway |
Glypican Pathway | Glypican Pathway |
HS-GAG Biosynthesis Pathway | HS-GAG Biosynthesis Pathway |
HS-GAG Degradation Pathway | HS-GAG Degradation Pathway |
Heparan Sulfate/heparin (HS-GAG) Metabolism Pathway | Heparan Sulfate/heparin (HS-GAG) Metabolism Pathway |
Diseases associated with GPC3 ELISA Kit
Neoplasms | publications with GPC3 and Neoplasms |
Carcinoma, Hepatocellular | publications with GPC3 and Carcinoma, Hepatocellular |
Liver Neoplasms | publications with GPC3 and Liver Neoplasms |
Liver Diseases | publications with GPC3 and Liver Diseases |
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1 | publications with GPC3 and SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1 |
Liver Cirrhosis | publications with GPC3 and Liver Cirrhosis |
Hepatitis | publications with GPC3 and Hepatitis |
Lung Neoplasms | publications with GPC3 and Lung Neoplasms |
Adenoma | publications with GPC3 and Adenoma |
Wilms Tumor | publications with GPC3 and Wilms Tumor |
Organs/Tissues associated with GPC3 ELISA Kit
Liver | publications with GPC3 and Liver |
Blood | publications with GPC3 and Blood |
Bone | publications with GPC3 and Bone |
Embryonic Tissue | publications with GPC3 and Embryonic Tissue |
Brain | publications with GPC3 and Brain |
Kidney | publications with GPC3 and Kidney |
Lung | publications with GPC3 and Lung |
Vascular | publications with GPC3 and Vascular |
Heart | publications with GPC3 and Heart |
Muscle | publications with GPC3 and Muscle |